Table 1.
Available vaccines and biologic therapy.
| Vaccine | Anti-TNF-a | Anti-IL-17 | Anti-IL-12/23 | Anti-IL-23 | Anti-IL-4/13 | Anti-IgE |
|---|---|---|---|---|---|---|
| Live-attenuated | Not indicated | Not indicated | Not indicated | Not indicated | Not indicated | Indicated ¶ |
| Inactivated influenza | Indicated | Indicated | Indicated | Indicated ¶ | Indicated | Indicated ¶ |
|
Pneumococcus
polysaccharide |
Indicated | Indicated | Indicated | Indicated ¶ | Indicated | Indicated ¶ |
| Other inactivated * | Indicated | Indicated | Indicated | Indicated ¶ | Indicated | Indicated ¶ |
|
Recombinant VZV
(Shingrix) |
Indicated | Indicated | Indicated | Indicated ¶ | Indicated | Indicated ¶ |
* Inactivated vaccines: hepatitis A, hepatitis B, diphtheria, Haemophilus influenzae b, Neisseria meningitides, human papillomavirus, influenza, pertussis, Streptococcus pneumoniae (conjugated), parenteral poliomyelitis, tetanus toxoid, parenteral typhoid fever, tick-borne encephalitis, trivalent subunit influenza; live-attenuated vaccines: oral poliomyelitis, mumps, measles, oral typhoid fever, yellow fever, varicella zoster. ¶ Not contraindicated according to the respective technical data sheet, but the level of evidence is lower due to the lack of specific studies about the vaccine.